TTL Antikörper
-
- Target Alle TTL Antikörper anzeigen
- TTL (Tubulin tyrosine Ligase (TTL))
-
Reaktivität
- Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TTL Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Ratte
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein corresponding to Mouse TTL
-
anti-Tubulin tyrosine Ligase (TTL) antibody
TTL Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Tubulin tyrosine Ligase (TTL) (AA 279-377) antibodyTTL Reaktivität: Human ELISA Wirt: Maus Monoclonal 1B2 unconjugated
-
- Applikationshinweise
- IHC/IF (M,R) 1:2000-1:4000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- TTL (Tubulin tyrosine Ligase (TTL))
- Andere Bezeichnung
- TTL (TTL Produkte)
- Hintergrund
- Tubulin-tyrosine ligase (TTL) is the enzyme responsible for the reversible addition of a tyrosine residue at the carboxyl end of alpha-tubulin. TTL forms stable complexes with tubulin and inhibit tubulin polymerization. TTL is frequently suppressed during tumor progression with resulting accumulation of detyrosinated alpha-tubulin in tumor cells. TTL suppression in human cancers is associated with increased tumor aggressiveness.
- Gen-ID
- 69737
- NCBI Accession
- NP_081468
- UniProt
- P38585
- Pathways
- Regulation of Cell Size
-
